Literature DB >> 23645473

Propensity for young reticulated platelet recruitment into arterial thrombi.

Robert D McBane1, Catherine Gonzalez, David O Hodge, Waldemar E Wysokinski.   

Abstract

Atherosclerosis reduces platelet survival and thereby increases the percentage of younger platelets in the circulation assuming steady-state thrombocytopoiesis. We hypothesized that younger platelets have an increased propensity for arterial thrombus participation compared to older counterparts. Platelet-rich thrombi were generated by perfusing human heparinized whole blood from normal donors over arterial cross-sections under shear conditions (3,350 s(-1)) corresponding to significant coronary artery stenosis using a perfusion chamber. Harvested thrombi were disaggregated, stained with thiazole orange, anti-integrin β3, glycoprotein (GP) Ibα, GP IX and P-selectin, and compared to paired whole blood samples from the same donor by flow cytometry. Thiazole orange staining intensity provides a measure of platelet m-RNA content and age. Thiazole orange staining intensity (MN ± SEM) of platelets harvested from thrombi (62 ± 13) was twofold greater compared to paired intra-individual whole blood samples (31 ± 1). Integrin β3 receptor density was also greater for thrombus platelets (12.0 ± 1.0) compared to whole blood platelets (7.0 ± 0.6; p < 0.0001). GPs Ibα and IX were reduced from thrombus platelets possibly reflecting shedding. Younger "reticulated" platelets appear to have a greater propensity for thrombus participation under shear conditions of coronary artery stenosis compared to older counterparts. This predisposition may be explained by an increased receptor density of integrin β3 in younger platelets. By this mechanism, the atherosclerotic process may enhance the individual propensity for arterial thrombosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23645473     DOI: 10.1007/s11239-013-0932-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  32 in total

1.  Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin.

Authors:  L Alberio; O Safa; K J Clemetson; C T Esmon; G L Dale
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

2.  Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes.

Authors:  J P McRedmond; S D Park; D F Reilly; J A Coppinger; P B Maguire; D C Shields; D J Fitzgerald
Journal:  Mol Cell Proteomics       Date:  2003-11-25       Impact factor: 5.911

Review 3.  "Message in the platelet"--more than just vestigial mRNA!

Authors:  Paul Harrison; Alison H Goodall
Journal:  Platelets       Date:  2008-09       Impact factor: 3.862

4.  Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.

Authors:  S Guthikonda; E I Lev; R Patel; T DeLao; A L Bergeron; J-F Dong; N S Kleiman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

5.  Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis.

Authors:  P H Levine; M Fisher; P B Schneider; R H Whitten; B H Weiner; I S Ockene; B F Johnson; M H Johnson; E M Doyle; P A Riendeau
Journal:  Arch Intern Med       Date:  1989-05

6.  Altered megakaryocyte-platelet-haemostatic axis in patients with acute stroke.

Authors:  Nicholas M Smith; Rohan Pathansali; Philip M W Bath
Journal:  Platelets       Date:  2002-03       Impact factor: 3.862

7.  Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.

Authors:  Eduardo Arellano-Rodrigo; Alberto Alvarez-Larrán; Juan-Carlos Reverter; Dolors Colomer; Neus Villamor; Beatriz Bellosillo; Francisco Cervantes
Journal:  Am J Hematol       Date:  2009-02       Impact factor: 10.047

8.  Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.

Authors:  V Fuster; J H Chesebro; R L Frye; L R Elveback
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

9.  Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.

Authors:  Sasidhar Guthikonda; Carlos L Alviar; Muthiah Vaduganathan; Mehmet Arikan; Armando Tellez; Timothy DeLao; Juan F Granada; Jing-Fei Dong; Neal S Kleiman; Eli I Lev
Journal:  J Am Coll Cardiol       Date:  2008-08-26       Impact factor: 24.094

10.  Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets.

Authors:  Wolfgang Bergmeier; Peter C Burger; Crystal L Piffath; Karin M Hoffmeister; John H Hartwig; Bernhard Nieswandt; Denisa D Wagner
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  9 in total

1.  Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes.

Authors:  Monica Verdoia; Chiara Sartori; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

Review 2.  Obesity and Altered Aspirin Pharmacology.

Authors:  Nicholas B Norgard
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

3.  Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.

Authors:  Constance C F M J Baaten; Leo F Veenstra; Rick Wetzels; Johanna P van Geffen; Frauke Swieringa; Susanne M de Witt; Yvonne M C Henskens; Harry Crijns; Sven Nylander; J J J van Giezen; Johan W M Heemskerk; Paola E J van der Meijden
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

4.  Proteome and functional decline as platelets age in the circulation.

Authors:  Harriet E Allan; Melissa A Hayman; Simone Marcone; Melissa V Chan; Matthew L Edin; Tania Maffucci; Abhishek Joshi; Laura Menke; Marilena Crescente; Manuel Mayr; Darryl C Zeldin; Paul C Armstrong; Timothy D Warner
Journal:  J Thromb Haemost       Date:  2021-08-27       Impact factor: 16.036

Review 5.  It's reticulated: the liver at the heart of atherosclerosis.

Authors:  Prabhakara R Nagareddy; Sunil K Noothi; Michelle C Flynn; Andrew J Murphy
Journal:  J Endocrinol       Date:  2018-05-02       Impact factor: 4.286

6.  Targeted erythropoietin selectively stimulates red blood cell expansion in vivo.

Authors:  Devin R Burrill; Andyna Vernet; James J Collins; Pamela A Silver; Jeffrey C Way
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

7.  Platelet turnover predicts outcome after coronary intervention.

Authors:  Matthias K Freynhofer; Liana Iliev; Veronika Bruno; Miklos Rohla; Florian Egger; Thomas W Weiss; Wolfgang Hübl; Martin Willheim; Johann Wojta; Kurt Huber
Journal:  Thromb Haemost       Date:  2017-02-23       Impact factor: 5.249

8.  Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies.

Authors:  Paul C Armstrong; Thomas Hoefer; Rebecca B Knowles; Arthur T Tucker; Melissa A Hayman; Plinio M Ferreira; Melissa V Chan; Timothy D Warner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

Review 9.  Reticulated Platelets-Which Functions Have Been Established by In Vivo and In Vitro Data?

Authors:  Muataz Ali Hamad; Nancy Schanze; Nicolas Schommer; Thomas Nührenberg; Daniel Duerschmied
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.